×
Century Therapeutics Income Taxes 2021-2024 | IPSC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Century Therapeutics income taxes from 2021 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.
View More
Century Therapeutics Income Taxes 2021-2024 | IPSC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Century Therapeutics income taxes from 2021 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.
Related Stocks
Company Name
Market
Cap
Zoetis (ZTS)
$79.8B
Takeda Pharmaceutical (TAK)
$42.6B
Sandoz Group AG (SDZNY)
$19.5B
Merck (MKKGY)
$19.1B
Astellas Pharma (ALPMY)
$18.3B
United Therapeutics (UTHR)
$16.6B
Summit Therapeutics (SMMT)
$14B
Neurocrine Biosciences (NBIX)
$12.7B
Shionogi (SGIOY)
$12B
Catalent (CTLT)
$11.1B
Madrigal Pharmaceuticals (MDGL)
$7.6B
Orion OYJ (ORINY)
$6.7B
Corcept Therapeutics (CORT)
$6B
Ionis Pharmaceuticals (IONS)
$5.4B
Crinetics Pharmaceuticals (CRNX)
$5.2B
PTC Therapeutics (PTCT)
$3.3B
Dyne Therapeutics (DYN)
$3B
AMNEAL PHARMACEUTICALS, INC (AMRX)
$2.6B
Catalyst Pharmaceuticals (CPRX)
$2.6B
Soleno Therapeutics (SLNO)
$2.5B
Centessa Pharmaceuticals (CNTA)
$2.2B
NewAmsterdam Pharma (NAMS)
$1.9B
Xencor (XNCR)
$1.8B
Recursion Pharmaceuticals (RXRX)
$1.6B
Evotec AG (EVO)
$1.6B
BioCryst Pharmaceuticals (BCRX)
$1.6B
Harrow (HROW)
$1.5B
Indivior (INDV)
$1.5B
Guardian Pharmacy Services (GRDN)
$1.5B
Ocular Therapeutix (OCUL)
$1.4B